| Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy IS Idilman, H Aniktar, R Idilman, G Kabacam, B Savas, A Elhan, A Celik, ... Radiology 267 (3), 767-775, 2013 | 437 | 2013 |
| Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta B Heidrich, C Yurdaydın, G Kabacam, BA Ratsch, K Zachou, B Bremer, ... Hepatology 60 (1), 87-97, 2014 | 325 | 2014 |
| Serum vitamin B12 and folate status in patients with inflammatory bowel diseases M Yakut, Y Üstün, G Kabaçam, I Soykan European journal of internal medicine 21 (4), 320-323, 2010 | 228 | 2010 |
| Interferon treatment duration in patients with chronic delta hepatitis and its effect on the natural course of the disease C Yurdaydin, O Keskin, Ç Kalkan, F Karakaya, A Çalişkan, G Kabaçam, ... The Journal of infectious diseases 217 (8), 1184-1192, 2018 | 106 | 2018 |
| Current status of liver transplantation in Europe PC Müller, G Kabacam, E Vibert, G Germani, H Petrowsky International Journal of Surgery 82, 22-29, 2020 | 95 | 2020 |
| HB eAg‐positive hepatitis delta: virological patterns and clinical long‐term outcome B Heidrich, B C. Serrano, R Idilman, G Kabaçam, B Bremer, R Raupach, ... Liver International 32 (9), 1415-1425, 2012 | 75 | 2012 |
| Entecavir treatment of chronic hepatitis D G Kabaçam, FO Önder, M Yakut, G Seven, SC Karatayli, E Karatayli, ... Clinical infectious diseases 55 (5), 645-650, 2012 | 63 | 2012 |
| İbn-i Sina Hastanesi Acil Servis’ ne başvuran hastaların sürveyans analizi O Polat, G Kabaçam, İ Güler, K Ergişi, A Yıldız Türkiye Acil Tıp Dergisi 5 (2), 78-81, 2005 | 42 | 2005 |
| The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country M Toy, FO Onder, R Idilman, G Kabacam, JH Richardus, M Bozdayi, ... The European Journal of Health Economics 13, 663-676, 2012 | 39 | 2012 |
| Autoimmune hepatitis triggered by COVID‐19: A report of two cases. G Kabaçam, S Wahlin, C Efe Liver International 41 (10), 2021 | 37 | 2021 |
| Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis Y Cakaloglu, MP Manns, H Wedemeyer Turk J Gastroenterol 23 (5), 560-568, 2012 | 33 | 2012 |
| Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation AJ Montano-Loza, V Ronca, M Ebadi, BE Hansen, G Hirschfield, S Elwir, ... Journal of hepatology 77 (1), 84-97, 2022 | 27 | 2022 |
| Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B O Keskin, AÇ Örmeci, B Baran, G Kabaçam, A Tüzün, E Karatayli, F Akyüz, ... Antiviral therapy 19 (6), 543-550, 2014 | 25 | 2014 |
| Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference JM Pollok, P Tinguely, M Berenguer, CU Niemann, DA Raptis, M Spiro, ... The Lancet Gastroenterology & Hepatology 8 (1), 81-94, 2023 | 23 | 2023 |
| Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D G Seven, SC Karatayli, SK Kose, M Yakut, G Kabacam, M Toruner, ... Turk J Gastroenterol 22 (3), 305-314, 2011 | 23 | 2011 |
| Clinical characteristics and evaluation of patients with large hiatal hernia and Cameron lesions M Yakut, G Kabaçam, A Öztürk, I Soykan Southern medical journal 104 (3), 179, 2011 | 18 | 2011 |
| Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir … E Karatayli, R Idilman, SC Karatayli, E Cevik, M Yakut, G Seven, ... Antiviral therapy 18 (1), 77-85, 2013 | 16 | 2013 |
| Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up F Karakaya, S Özer, Ç Kalkan, EA Tüzün, A Çalişkan, O Keskin, ... Antiviral Therapy 22 (7), 559-570, 2017 | 13 | 2017 |
| 398 characterization of the inactive HBsAg carrier state with 3 year follow-up M Yakut, M Bektas, G Seven, G Kabaçam, E Karatayli, S Karatayli, ... Journal of hepatology, S159, 2011 | 13 | 2011 |
| The natural course of non-alcoholic fatty liver disease GC Seval, G Kabacam, M Yakut, G Seven, B Savas, A Elhan, K Cinar, ... Hepatology Forum 1 (1), 20, 2020 | 12 | 2020 |
A.Mithat BOZDAYIANKARA UNIVERSITY在 medicine.ankara.edu.tr 的电子邮件经过验证
